Tirado-Vélez, J.M.; Carreño, D.; Sevillano, D.; Alou, L.; Yuste, J.; de la Campa, A.G.
Seconeolitsine, the Novel Inhibitor of DNA Topoisomerase I, Protects against Invasive Pneumococcal Disease Caused by Fluoroquinolone-Resistant Strains. Antibiotics 2021, 10, 573.
https://doi.org/10.3390/antibiotics10050573
AMA Style
Tirado-Vélez JM, Carreño D, Sevillano D, Alou L, Yuste J, de la Campa AG.
Seconeolitsine, the Novel Inhibitor of DNA Topoisomerase I, Protects against Invasive Pneumococcal Disease Caused by Fluoroquinolone-Resistant Strains. Antibiotics. 2021; 10(5):573.
https://doi.org/10.3390/antibiotics10050573
Chicago/Turabian Style
Tirado-Vélez, Jose Manuel, David Carreño, David Sevillano, Luis Alou, José Yuste, and Adela G. de la Campa.
2021. "Seconeolitsine, the Novel Inhibitor of DNA Topoisomerase I, Protects against Invasive Pneumococcal Disease Caused by Fluoroquinolone-Resistant Strains" Antibiotics 10, no. 5: 573.
https://doi.org/10.3390/antibiotics10050573
APA Style
Tirado-Vélez, J. M., Carreño, D., Sevillano, D., Alou, L., Yuste, J., & de la Campa, A. G.
(2021). Seconeolitsine, the Novel Inhibitor of DNA Topoisomerase I, Protects against Invasive Pneumococcal Disease Caused by Fluoroquinolone-Resistant Strains. Antibiotics, 10(5), 573.
https://doi.org/10.3390/antibiotics10050573